Product NDC: | 15054-0500 |
Proprietary Name: | Dysport |
Non Proprietary Name: | Botulinum Toxin Type A |
Active Ingredient(s): | 500 U/1 & nbsp; Botulinum Toxin Type A |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 15054-0500 |
Labeler Name: | Ipsen Biopharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125274 |
Marketing Category: | BLA |
Start Marketing Date: | 20091102 |
Package NDC: | 15054-0500-1 |
Package Description: | 1 VIAL in 1 CARTON (15054-0500-1) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
NDC Code | 15054-0500-1 |
Proprietary Name | Dysport |
Package Description | 1 VIAL in 1 CARTON (15054-0500-1) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Product NDC | 15054-0500 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Botulinum Toxin Type A |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20091102 |
Marketing Category Name | BLA |
Labeler Name | Ipsen Biopharmaceuticals, Inc. |
Substance Name | BOTULINUM TOXIN TYPE A |
Strength Number | 500 |
Strength Unit | U/1 |
Pharmaceutical Classes | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |